Results 51 to 60 of about 24,575,655 (169)
CLEC‐2 is not required for platelet aggregation at arteriolar shear [PDF]
The C-type lectin receptor CLEC-2 is expressed primarily on the surface of platelets, where it is present as a dimer, and is found at low level on a subpopulation of other hematopoietic cells, including mouse neutrophils [1–4] Clustering of CLEC-2 by the snake venom toxin rhodocytin, specific antibodies or its endogenous ligand, podoplanin, elicits ...
Craig E, Hughes +5 more
openaire +2 more sources
CLEC-2 is required for development and maintenance of lymph nodes [PDF]
Key Points CLEC-2 is necessary for lymphatic cell proliferation and lymph node anlage persistence after birth. Lack of CLEC-2 expression on megakaryocytes and platelets compromises lymph node integrity in adult life.
Cécile, Bénézech +10 more
openaire +2 more sources
The novel platelet activation receptor CLEC-2
The c-type lectin-like receptor 2 (CLEC-2) was first identified from a bio-informatic screen for c-type lectin-like receptors. However, neither its function nor its ligand(s) had been elucidated for several years. In 2006, we reported that the receptor is expressed on the surface of platelets and serves as a receptor for the snake venom rhodocytin ...
Katsue, Suzuki-Inoue +2 more
openaire +2 more sources
Background Platelets are associated with HIV in the blood of infected individuals and might modulate viral dissemination, particularly if the virus is directly transmitted into the bloodstream.
Münch Jan +10 more
doaj +1 more source
The Platelet Receptor CLEC-2 Is Active as a Dimer
The platelet receptor CLEC-2 binds to the snake venom toxin rhodocytin and the tumor cell surface protein podoplanin. Binding of either of these ligands promotes phosphorylation of a single tyrosine residue in the YXXL motif in the intracellular domain of CLEC-2.
Watson, A. +9 more
openaire +3 more sources
(A) Slot blot analysis of the levels of podoplanin and CLEC-2 in the elution fraction from complexes formed in the presence or absence of the indicated concentrations of hematoporphyrin (HPy) or 2CP.
Yusuke Suzuki (525707) +10 more
core +1 more source
Lymphatic blood filling in CLEC-2-deficient mouse models
C-type lectin-like receptor 2 (CLEC-2) is considered as a potential drug target in settings of wound healing, inflammation, and infection. A potential barrier to this is evidence that CLEC-2 and its ligand podoplanin play a critical role in preventing ...
Babak J Mehrara (8530731) +13 more
core +1 more source
Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome
Podoplanin (PDPN) promotes platelet aggregation and activation by interacting with C-type lectin-like receptor 2(CLEC-2) on platelets. The interaction between the upregulated PDPN and platelet CLEC-2 stimulates venous thrombosis. PDPN was identified as a
Ying Ji MD +8 more
doaj +1 more source
CLEC-2/PDPN signalling phospho proteomics
Fold difference values from TMT proteomics of total protein and phosphopeptides, 5 biological replicates: control vs CLEC-2 stimulated. 15 minutes and 24 hour time points.Relating to Figure 3dAbstractLymph nodes (LNs) work as filtering organs, constantly
Chris Tape (6782324) +2 more
core +1 more source
IgG Glycosylation‐Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis
Objective Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE) that can lead to end‐stage kidney disease and increased mortality. IgG from patients with LN displays abnormal glycosylation, contributing to podocyte injury.
Rohit Upadhyay +3 more
wiley +1 more source

